| Literature DB >> 1450705 |
G Fattovich1, C Betterle, L Brollo, G Giustina, B Pedini, A Alberti.
Abstract
Thirty-two patients with chronic hepatitis B treated with alpha interferon were tested for 12 different antibodies. Only a minority (18%) of cases developed antinuclear antibodies and none developed clinical signs of autoimmune disease. These data suggest that, at the dose regimen used, interferon therapy of chronic hepatitis B is not associated with triggering of autoimmunity.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1450705 DOI： 10.1007/978-3-7091-5633-9_65
Source DB: PubMed Journal: Arch Virol Suppl ISSN： 0939-1983